课题基金 / 基金详情

Mechanisms of ligand discrimination by the T cell signaling machinery

Mechanisms of ligand discrimination by the T cell signaling machinery
T 细胞信号传导机制的配体辨别机制
批准号:
10673732
负责人:
Adam Courtney
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-06-30

项目摘要

项目成果

Adam Courtney的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY T cells can discriminate between diseased and non-diseased states. To make this distinction, the information provided by extracellular receptors must be interpreted by signaling networks within the T cell. Most notable is T cell antigen receptor (TCR) signaling network because it combines a receptor that scans the surface of human cells for threats and signaling proteins that ensure a highly sensitive and specific response. This TCR signaling machinery can detect small quantities of an antigenic agonist and discriminate it from a background of structurally similar endogenous ligands. The overarching goal of my research group is to elucidate how the TCR signaling machinery discriminates between TCR ligands by producing distinct signaling outcomes. The past few decades have revealed how the TCR is coupled to signaling proteins within the T cell, but much less is known about how these signaling proteins are coordinated to produce different cellular responses, such as whether a TCR ligand should be ignored, or cause the T cell to become activated. The underlying mechanisms used to produce context- specific TCR signals must be determined to fully realize the potential of T cells as therapeutic entities for the treatment of human disease. Regulatory mechanisms can diversify signaling by controlling the activity of signaling proteins, such as kinases, and their assembly into protein complexes. We propose to determine how TCR signal diversification can arise from (1) negative feedback loops, (2) differential assembly of signaling complexes, and (3) adaptive desensitization of TCR signaling. To interrogate these mechanisms of signal diversification and their effect on a T cell response, we will combine chemical tools with immunological approaches. We will use proximity labeling and mass spectrometry analyses to determine how the composition of signaling complexes is altered by kinase-responsive negative feedback and TCR-ligand binding properties. We will also evaluate more long-term mechanisms of receptor desensitization caused by adaptive transcriptional changes by RNA sequencing. These datasets will be generated and analyzed with our collaborators at the University of Michigan Medical School, which includes the Proteomics Resource Facility and Advanced Genomics Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STARTUP Central
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: